Sang Ryong Jeon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sang Ryong Jeon has a total of 255 co-authors. Here are the top co-authors by number of shared publications:
- Jin Hoon Park
Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
19 shared publications Jin Hoon Park
Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea
17 shared publications- Sung Woo Roh
Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
16 shared publications - Hyung Ho Yoon
Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea
10 shared publications Sung Woo Roh
Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
10 shared publicationsHong Kyung Shin
Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea
9 shared publications
Latest Publications
- 2 October 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Clinical Importance and Usefulness of Direct Targeting of the Ventral Intermediate Nucleus of the Thalamus Using Fluid and White Matter Suppression Imaging at 3T MRI
BACKGROUND AND OBJECTIVES: Stereotactic targeting of the ventral intermediate nucleus of the thalamus (Vim) in tremor surgery traditionally relies on indirect, atlas-based coordinates, whereas direct visualization of the Vim using advanced MRI sequences has the potential to improve targeting precision and clinical outcomes. We evaluated the feasibility and clinical utility of fluid and white matter suppression (FLAWS) imaging for direct Vim targeting in the MRI-guided focused ultrasound (MRgFUS) procedure. METHODS: We retrospectively reviewed 30 MRgFUS procedures in 29 patients. Cases were divided into conventional indirect targeting (non-FLAWS group, n = 15) and direct targeting (FLAWS group, n = 15). We compared initial targeting accuracy (positive clinical response at the first target location), procedural metrics, and clinical outcomes. RESULTS: The Vim was reliably delineated on FLAWS imaging as a hypointense region at 14.7 ± 1.2 mm lateral (10.7 ± 1.4 mm from the medial border of the thalamus), 7.3 ± 0.7 mm anterior, and 0.4 ± 0.5 mm inferior relative to the posterior commissure, representing a more anterior location (29.2% ± 2.9% of the intercommissural line from the posterior commissure) compared with conventional indirect Vim coordinates. In comparing the 2 targeting strategies, the FLAWS group demonstrated significantly higher initial targeting accuracy (86.7% vs 40.0%; P = .021) and a lower number of target realignments (3.0 vs 6.0; P = .003) than the non-FLAWS group. Regarding clinical outcomes, the FLAWS group exhibited a trend toward a lower incidence of sensory adverse effects (20.0% vs 46.7%) and tremor recurrence (0.0% vs 13.3%) compared with the non-FLAWS group, although this did not reach statistical significance. CONCLUSION: Direct image-based targeting of the Vim using FLAWS imaging at 3T MRI is feasible and offers practical advantages by improving initial targeting accuracy and reducing the need for target realignments in the MRgFUS procedure.
- 2 October 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Clinical Importance and Usefulness of Direct Targeting of the Ventral Intermediate Nucleus of the Thalamus Using Fluid and White Matter Suppression Imaging at 3T MRI
BACKGROUND AND OBJECTIVES: Stereotactic targeting of the ventral intermediate nucleus of the thalamus (Vim) in tremor surgery traditionally relies on indirect, atlas-based coordinates, whereas direct visualization of the Vim using advanced MRI sequences has the potential to improve targeting precision and clinical outcomes. We evaluated the feasibility and clinical utility of fluid and white matter suppression (FLAWS) imaging for direct Vim targeting in the MRI-guided focused ultrasound (MRgFUS) procedure. METHODS: We retrospectively reviewed 30 MRgFUS procedures in 29 patients. Cases were divided into conventional indirect targeting (non-FLAWS group, n = 15) and direct targeting (FLAWS group, n = 15). We compared initial targeting accuracy (positive clinical response at the first target location), procedural metrics, and clinical outcomes. RESULTS: The Vim was reliably delineated on FLAWS imaging as a hypointense region at 14.7 ± 1.2 mm lateral (10.7 ± 1.4 mm from the medial border of the thalamus), 7.3 ± 0.7 mm anterior, and 0.4 ± 0.5 mm inferior relative to the posterior commissure, representing a more anterior location (29.2% ± 2.9% of the intercommissural line from the posterior commissure) compared with conventional indirect Vim coordinates. In comparing the 2 targeting strategies, the FLAWS group demonstrated significantly higher initial targeting accuracy (86.7% vs 40.0%; P = .021) and a lower number of target realignments (3.0 vs 6.0; P = .003) than the non-FLAWS group. Regarding clinical outcomes, the FLAWS group exhibited a trend toward a lower incidence of sensory adverse effects (20.0% vs 46.7%) and tremor recurrence (0.0% vs 13.3%) compared with the non-FLAWS group, although this did not reach statistical significance. CONCLUSION: Direct image-based targeting of the Vim using FLAWS imaging at 3T MRI is feasible and offers practical advantages by improving initial targeting accuracy and reducing the need for target realignments in the MRgFUS procedure.
- Open Access
- 13 May 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (10) , 1329
Long-Term Risk of Parkinson’s Disease Following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study
Background/Objectives: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder linked to gut–brain axis dysregulation. Gastrointestinal dysfunction has been implicated in the prodromal phase of Parkinson’s disease (PD), but long-term population-based evidence remains limited. Methods: Using the Korean National Health Insurance Service database (2012–2023), we conducted a nationwide matched cohort study including 142,668 patients with IBS and 285,336 matched individssuals without IBS. IBS was defined by at least two ICD-10 diagnoses with a three-year washout period to reduce reverse causation. Participants were followed for up to nine years for incident PD. Incidence rate ratios (IRRs), Kaplan–Meier analyses, and multivariable Cox models were applied. Results: IBS was associated with a higher incidence of PD (IRR, 1.24; 95% CI, 1.14–1.36). The magnitude and statistical significance of the association varied across age- and sex-stratified analyses, with the highest crude relative risk observed among women younger than 60 years. In fully adjusted Cox models, IBS remained significantly associated with PD in the overall population (hazard ratio, 1.38; 95% CI, 1.18–1.62), with statistical significance retained particularly among women in subgroup analyses. Sensitivity analyses using alternative definitions yielded consistent results. Conclusions: In this nationwide cohort, IBS was associated with an increased long-term risk of PD after adjustment for measured covariates. Given the observational claims-based design, these findings should be interpreted cautiously as hypothesis-generating epidemiological evidence requiring further validation.
- 13 May 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (10) , 1329
Open AccessLong-Term Risk of Parkinson’s Disease Following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study
Background/Objectives: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder linked to gut–brain axis dysregulation. Gastrointestinal dysfunction has been implicated in the prodromal phase of Parkinson’s disease (PD), but long-term population-based evidence remains limited. Methods: Using the Korean National Health Insurance Service database (2012–2023), we conducted a nationwide matched cohort study including 142,668 patients with IBS and 285,336 matched individssuals without IBS. IBS was defined by at least two ICD-10 diagnoses with a three-year washout period to reduce reverse causation. Participants were followed for up to nine years for incident PD. Incidence rate ratios (IRRs), Kaplan–Meier analyses, and multivariable Cox models were applied. Results: IBS was associated with a higher incidence of PD (IRR, 1.24; 95% CI, 1.14–1.36). The magnitude and statistical significance of the association varied across age- and sex-stratified analyses, with the highest crude relative risk observed among women younger than 60 years. In fully adjusted Cox models, IBS remained significantly associated with PD in the overall population (hazard ratio, 1.38; 95% CI, 1.18–1.62), with statistical significance retained particularly among women in subgroup analyses. Sensitivity analyses using alternative definitions yielded consistent results. Conclusions: In this nationwide cohort, IBS was associated with an increased long-term risk of PD after adjustment for measured covariates. Given the observational claims-based design, these findings should be interpreted cautiously as hypothesis-generating epidemiological evidence requiring further validation.
- Open Access
- 12 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Optogenetic regulation of chloride ions in reactive astrocytes may mitigate Parkinson’s disease pathology
Recent investigations underscore the pivotal role of reactive astrocytes in the pathogenesis of Parkinson’s disease (PD). As PD advances, reactive astrocytes lose their ability to degrade α-Synuclein (α-Syn) aggregates while concurrently increasing r-aminobutyric acid (GABA) secretion, which heightens inhibition of DA neurons and worsens the disease. This study explored optogenetic manipulation of reactive astrocytes as a therapeutic strategy. Halorhodopsin (NpHR), a chloride pump, was expressed in reactive astrocytes within the substantia nigra pars compacta (SNpc) of an A53T α-Syn overexpression PD rat model. Optogenetic stimulation of NpHR led to a 72.6% reduction in GABA level (p = 0.0486) and a 67.5% decrease in α-Syn aggregates (p < 0.0001) within the SNpc. Furthermore, contralateral forelimb akinesia was significantly improved by 81.4 ± 7.2% (71.6–90.9%) post-illumination in the NpHR group compared with the pre-illumination state (p = 0.0002). These results suggest that the optogenetic modulation of reactive astrocytes can alleviate astrocytic aberrant tonic inhibition of DA neurons, resulting in the revitalization of DA neurons and enhancing the degradation of α-Syn aggregates. This mechanism may ultimately ameliorate parkinsonian motor symptoms, suggesting a promising novel therapeutic avenue for PD.
- 12 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessOptogenetic regulation of chloride ions in reactive astrocytes may mitigate Parkinson’s disease pathology
Recent investigations underscore the pivotal role of reactive astrocytes in the pathogenesis of Parkinson’s disease (PD). As PD advances, reactive astrocytes lose their ability to degrade α-Synuclein (α-Syn) aggregates while concurrently increasing r-aminobutyric acid (GABA) secretion, which heightens inhibition of DA neurons and worsens the disease. This study explored optogenetic manipulation of reactive astrocytes as a therapeutic strategy. Halorhodopsin (NpHR), a chloride pump, was expressed in reactive astrocytes within the substantia nigra pars compacta (SNpc) of an A53T α-Syn overexpression PD rat model. Optogenetic stimulation of NpHR led to a 72.6% reduction in GABA level (p = 0.0486) and a 67.5% decrease in α-Syn aggregates (p < 0.0001) within the SNpc. Furthermore, contralateral forelimb akinesia was significantly improved by 81.4 ± 7.2% (71.6–90.9%) post-illumination in the NpHR group compared with the pre-illumination state (p = 0.0002). These results suggest that the optogenetic modulation of reactive astrocytes can alleviate astrocytic aberrant tonic inhibition of DA neurons, resulting in the revitalization of DA neurons and enhancing the degradation of α-Syn aggregates. This mechanism may ultimately ameliorate parkinsonian motor symptoms, suggesting a promising novel therapeutic avenue for PD.
- Open Access
- 31 October 2025
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 18 (4) , 327-336
Connectivity-Based Analysis of the Stimulation Effects of Globus Pallidus Interna Deep Brain Stimulation in Parkinson’s Disease: A Focus on Freezing of Gait
Objective Freezing of gait (FOG) significantly affects quality of life and increases the risk of falls in patients with Parkinson’s disease (PD). Although deep brain stimulation (DBS) of the globus pallidus interna (GPi) is effective in managing motor complications, its efficacy in treating FOG remains inconsistent. This study aimed to determine whether preoperative structural brain connectivity can predict both the presence of FOG and its postoperative improvement following GPi DBS.Methods We retrospectively analyzed 58 patients with PD who underwent GPi DBS. Preoperative diffusion tensor imaging was used to assess structural connectivity between the volume of activated tissue (VAT) and 82 cortical regions. Machine learning models were developed to predict baseline FOG and postoperative FOG improvement (defined as a ≥1- or ≥2-point reduction) using demographic and connectivity features.Results Machine learning models incorporating structural connectivity features between the VAT and cortical regions—including the prefrontal, cingulate, and premotor cortices—outperformed models based solely on demographic variables in predicting both the presence of preoperative FOG and postoperative improvement. For example, the support vector machine model to predict FOG improvement (≥1-point improvement) achieved an accuracy of 0.65 with demographic data alone, which increased to 0.77 with the addition of structural connectivity features. Similar performance enhancements were observed in sensitivity analyses using stricter FOG thresholds (≥2-point improvement).Conclusion Preoperative structural connectivity between the GPi and key cortical regions involved in cognitive control and motor planning predicts FOG responsiveness to DBS. These results highlight the utility of connectomic biomarkers for personalizing DBS strategies and optimizing therapeutic outcomes in patients with advanced PD.
- 31 October 2025
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 18 (4) , 327-336
Open AccessConnectivity-Based Analysis of the Stimulation Effects of Globus Pallidus Interna Deep Brain Stimulation in Parkinson’s Disease: A Focus on Freezing of Gait
Objective Freezing of gait (FOG) significantly affects quality of life and increases the risk of falls in patients with Parkinson’s disease (PD). Although deep brain stimulation (DBS) of the globus pallidus interna (GPi) is effective in managing motor complications, its efficacy in treating FOG remains inconsistent. This study aimed to determine whether preoperative structural brain connectivity can predict both the presence of FOG and its postoperative improvement following GPi DBS.Methods We retrospectively analyzed 58 patients with PD who underwent GPi DBS. Preoperative diffusion tensor imaging was used to assess structural connectivity between the volume of activated tissue (VAT) and 82 cortical regions. Machine learning models were developed to predict baseline FOG and postoperative FOG improvement (defined as a ≥1- or ≥2-point reduction) using demographic and connectivity features.Results Machine learning models incorporating structural connectivity features between the VAT and cortical regions—including the prefrontal, cingulate, and premotor cortices—outperformed models based solely on demographic variables in predicting both the presence of preoperative FOG and postoperative improvement. For example, the support vector machine model to predict FOG improvement (≥1-point improvement) achieved an accuracy of 0.65 with demographic data alone, which increased to 0.77 with the addition of structural connectivity features. Similar performance enhancements were observed in sensitivity analyses using stricter FOG thresholds (≥2-point improvement).Conclusion Preoperative structural connectivity between the GPi and key cortical regions involved in cognitive control and motor planning predicts FOG responsiveness to DBS. These results highlight the utility of connectomic biomarkers for personalizing DBS strategies and optimizing therapeutic outcomes in patients with advanced PD.
- Open Access
- 1 September 2025
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 68 (5) , 541-550
Neurochemical Characterization of A53T-Alpha-Synuclein and 6-Hydroxydopamine Rat Models for Parkinson’s Disease through Animal PET Imaging Analysis
Objective : In preclinical research of Parkinson’s disease, several rodent models, notably the classical 6-hydroxydopamine (6-OHDA) model and the A53T-alpha-synuclein model, have been widely used, yet their distinct neurochemical characteristics in conjunction with behavioral and histopathological changes have been scarcely documented.Methods : We examined the two rat models of Parkinson’s disease and characterized them using [18F]fluoropropyl-carbomethoxyiodophenyltropane (FP-CIT) animal positron emission tomography (PET) imaging. The 6-OHDA model (n=10) was induced by unilateral injection of 6-OHDA into the middle forebrain bundle, while the A53T-alpha-synuclein model (n=10) was mediated by the adeno-associated viral vectors injected into the substantia nigra. We hypothesized that these models would present differential neurochemical profiles, which could reflect their behavioral and histopathological features and potentially serve as a supplementary tool for evaluating the outcomes of interventions in animal experiments.Results : The striatum showed decreased PET uptake on the affected side compared to the unaffected control side, which was highly correlated with the stepping behaviors (R=0.854; 95% confidence interval [CI], 0.606 to 0.951). The decrease in striatal PET uptake was more pronounced in the 6-OHDA model than in the A53T-alpha-synuclein model : the 6-OHDA model exhibited a 60% decrease (95% CI, 48% to 65%) in the affected side compared the control side, while the A53T-alpha-synuclein model exhibited a 20% decrease (95% CI, -16% to 47%). Interestingly, PET uptake in the forebrain cortical region, including the motor cortex, was exclusively decreased in the 6-OHDA model (p=1.0×10-4 and p=1.2×10-3, respectively), indicating that 6-OHDA model is affected not only in the nigrostriatal system but also in other cortical regions. Conversely, the A53T-alpha-synuclein model showed no significant alterations in these cortical regions.Conclusion : Although the A53T-alpha-synuclein model demonstrates less definitive behavioral changes compared to the 6-OHDA model, it presents a more confined pathophysiological representation of Parkinson’s disease and may be better suited for evaluating certain therapeutic interventions when utilized with adequate neurochemical characterization.
- 1 September 2025
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 68 (5) , 541-550
Open AccessNeurochemical Characterization of A53T-Alpha-Synuclein and 6-Hydroxydopamine Rat Models for Parkinson’s Disease through Animal PET Imaging Analysis
Objective : In preclinical research of Parkinson’s disease, several rodent models, notably the classical 6-hydroxydopamine (6-OHDA) model and the A53T-alpha-synuclein model, have been widely used, yet their distinct neurochemical characteristics in conjunction with behavioral and histopathological changes have been scarcely documented.Methods : We examined the two rat models of Parkinson’s disease and characterized them using [18F]fluoropropyl-carbomethoxyiodophenyltropane (FP-CIT) animal positron emission tomography (PET) imaging. The 6-OHDA model (n=10) was induced by unilateral injection of 6-OHDA into the middle forebrain bundle, while the A53T-alpha-synuclein model (n=10) was mediated by the adeno-associated viral vectors injected into the substantia nigra. We hypothesized that these models would present differential neurochemical profiles, which could reflect their behavioral and histopathological features and potentially serve as a supplementary tool for evaluating the outcomes of interventions in animal experiments.Results : The striatum showed decreased PET uptake on the affected side compared to the unaffected control side, which was highly correlated with the stepping behaviors (R=0.854; 95% confidence interval [CI], 0.606 to 0.951). The decrease in striatal PET uptake was more pronounced in the 6-OHDA model than in the A53T-alpha-synuclein model : the 6-OHDA model exhibited a 60% decrease (95% CI, 48% to 65%) in the affected side compared the control side, while the A53T-alpha-synuclein model exhibited a 20% decrease (95% CI, -16% to 47%). Interestingly, PET uptake in the forebrain cortical region, including the motor cortex, was exclusively decreased in the 6-OHDA model (p=1.0×10-4 and p=1.2×10-3, respectively), indicating that 6-OHDA model is affected not only in the nigrostriatal system but also in other cortical regions. Conversely, the A53T-alpha-synuclein model showed no significant alterations in these cortical regions.Conclusion : Although the A53T-alpha-synuclein model demonstrates less definitive behavioral changes compared to the 6-OHDA model, it presents a more confined pathophysiological representation of Parkinson’s disease and may be better suited for evaluating certain therapeutic interventions when utilized with adequate neurochemical characterization.
- Open Access
- 30 June 2025
- Published by The Korean Spinal Neurosurgery Society in Neurospine
- Vol. 22 (2) , 603-612
Anterior Corpectomy Versus Posterior Pedicle Screw Fixation With 5.5-mm Rods for Metastatic Spinal Tumor Located in the Cervicothoracic Junction
Objective: This study compared the efficacy of posterior pedicle screw fixation with 5.5-mm rods (PPSF5.5) with anterior corpectomy (AC) for metastatic cervicothoracic junction (CTJ) tumors.Methods: This retrospective analysis included patients with CTJ tumors who underwent PPSF5.5 or AC from January 2000 to December 2023. Data collected included demographics, surgical details, clinical outcomes (visual analogue scale scores for neck or back pain, Spinal Instability Neoplastic Scale score, McCormick scale, Nurick grade, and Eastern Cooperative Oncology Group score), radiologic results (cervical segmental Cobb angle), and surgical complications (instrumentation failure, tumor regrowth, and wound infection).Results: The AC group showed a tendency for short-level fusion. Patients in this group had tumors primarily located near C7 and generally confined to the vertebral body. AC was associated with more significant postoperative kyphotic changes in the index vertebra during follow-up than PPSF5.5. Moreover, AC was associated with a higher incidence of instrumentation failure, necessitating revision surgeries. Conversely, patients in the PPSF5.5 group tended to require revision surgery due to tumor regrowth.Conclusion: For CTJ metastatic tumors, PPSF5.5 provides superior resistance to forward bending and collapse prevention and minimizes instrumentation failure rate compared to AC. Moreover, AC may reduce the risk of tumor recurrence, but this approach is recommended only if the tumor is confined to the vertebral body and located at the upper level of the CTJ.
- 30 June 2025
- Published by The Korean Spinal Neurosurgery Society in Neurospine
- Vol. 22 (2) , 603-612
Open AccessAnterior Corpectomy Versus Posterior Pedicle Screw Fixation With 5.5-mm Rods for Metastatic Spinal Tumor Located in the Cervicothoracic Junction
Objective: This study compared the efficacy of posterior pedicle screw fixation with 5.5-mm rods (PPSF5.5) with anterior corpectomy (AC) for metastatic cervicothoracic junction (CTJ) tumors.Methods: This retrospective analysis included patients with CTJ tumors who underwent PPSF5.5 or AC from January 2000 to December 2023. Data collected included demographics, surgical details, clinical outcomes (visual analogue scale scores for neck or back pain, Spinal Instability Neoplastic Scale score, McCormick scale, Nurick grade, and Eastern Cooperative Oncology Group score), radiologic results (cervical segmental Cobb angle), and surgical complications (instrumentation failure, tumor regrowth, and wound infection).Results: The AC group showed a tendency for short-level fusion. Patients in this group had tumors primarily located near C7 and generally confined to the vertebral body. AC was associated with more significant postoperative kyphotic changes in the index vertebra during follow-up than PPSF5.5. Moreover, AC was associated with a higher incidence of instrumentation failure, necessitating revision surgeries. Conversely, patients in the PPSF5.5 group tended to require revision surgery due to tumor regrowth.Conclusion: For CTJ metastatic tumors, PPSF5.5 provides superior resistance to forward bending and collapse prevention and minimizes instrumentation failure rate compared to AC. Moreover, AC may reduce the risk of tumor recurrence, but this approach is recommended only if the tumor is confined to the vertebral body and located at the upper level of the CTJ.
- Open Access
- 26 June 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (13) , 4540
BioGlue® Induced Mass Formation Aggravating Spinal Canal Invasion After Intradural Tumor Surgery
Background/Objectives: The aim of this study was to evaluate whether the use of BioGlue® increases the risk of postoperative mass formation and subsequent spinal canal invasion after intradural spinal tumor surgery. Methods: After retrospectively reviewing patients who underwent intradural tumor surgery from 2018 to 2023, we evaluated mass formation as detected in postoperative MRI according to the Epidural Spinal Cord Compression (ESCC) grade. Patients were divided into two groups based on the use of BioGlue®, and we analyzed MRI postoperatively to compare the differences in ESCC grades and the incidence of symptomatic spinal canal invasion between the two groups. Additionally, we performed a logistic regression analysis to identify risk factors associated with mass formation and to explore their relationship with BioGlue®. Results: This study included a total of 153 patients, 87 in the BioGlue® and 66 in the non-BioGlue® groups. In the BioGlue® group, 18 patients had ESCC grade 2, and 11 had grade 3. Conversely, in the non-BioGlue® group, only 8 patients had ESCC grade 2, and none had grade 3 (p = 0.001). Among the cases of symptomatic spinal canal invasion, all five cases were identified in the BioGlue® group (p = 0.001). Both univariate and multivariate analyses showed that BioGlue® was a significant risk factor for spinal canal invasion (univariate: OR = 3.931, p = 0.005, multivariate: OR = 3.812, p = 0.003). Conclusions: Our findings indicated that BioGlue® was a significant risk factor for mass formation aggravating spinal canal invasion after intradural tumor surgery.
- 26 June 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (13) , 4540
Open AccessBioGlue® Induced Mass Formation Aggravating Spinal Canal Invasion After Intradural Tumor Surgery
Background/Objectives: The aim of this study was to evaluate whether the use of BioGlue® increases the risk of postoperative mass formation and subsequent spinal canal invasion after intradural spinal tumor surgery. Methods: After retrospectively reviewing patients who underwent intradural tumor surgery from 2018 to 2023, we evaluated mass formation as detected in postoperative MRI according to the Epidural Spinal Cord Compression (ESCC) grade. Patients were divided into two groups based on the use of BioGlue®, and we analyzed MRI postoperatively to compare the differences in ESCC grades and the incidence of symptomatic spinal canal invasion between the two groups. Additionally, we performed a logistic regression analysis to identify risk factors associated with mass formation and to explore their relationship with BioGlue®. Results: This study included a total of 153 patients, 87 in the BioGlue® and 66 in the non-BioGlue® groups. In the BioGlue® group, 18 patients had ESCC grade 2, and 11 had grade 3. Conversely, in the non-BioGlue® group, only 8 patients had ESCC grade 2, and none had grade 3 (p = 0.001). Among the cases of symptomatic spinal canal invasion, all five cases were identified in the BioGlue® group (p = 0.001). Both univariate and multivariate analyses showed that BioGlue® was a significant risk factor for spinal canal invasion (univariate: OR = 3.931, p = 0.005, multivariate: OR = 3.812, p = 0.003). Conclusions: Our findings indicated that BioGlue® was a significant risk factor for mass formation aggravating spinal canal invasion after intradural tumor surgery.
- Open Access
- 1 January 2025
- Published by XMLink in Korean Journal of Neurotrauma
- Vol. 21 (4) , 265-277
Intramedullary Neural Stem Cell Transplantation in Spinal Cord Injury: Timing, Targets, and Techniques
Kwon S, et al. Korean J Neurotrauma. 2025 Oct;21:e36. https://doi.org/10.13004/kjnt.2025.21.e36
- 1 January 2025
- Published by XMLink in Korean Journal of Neurotrauma
- Vol. 21 (4) , 265-277
Open AccessIntramedullary Neural Stem Cell Transplantation in Spinal Cord Injury: Timing, Targets, and Techniques
Kwon S, et al. Korean J Neurotrauma. 2025 Oct;21:e36. https://doi.org/10.13004/kjnt.2025.21.e36